AGTC - Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q2 2021 Results - Earnings Call Transcript
Applied Genetic Technologies Corporation (AGTC) Q2 2021 Earnings Conference Call February 11, 2021 08:00 AM ET Company Participants Sue Washer - Chief Executive Officer Mark Shearman - Chief Scientific Officer Bill Sullivan - Chief Financial Officer Conference Call Participants Jim Birchenough - Wells Fargo Joe Pantginis - H.C. Wainwright Matthew Luchini - BMO Capital Markets Kristen Kluska - Cantor Fitzgerald Zegbeh Jallah - ROTH Capital Partners Presentation Operator Good morning, and welcome to the AGTC Financial Results Conference call for the Second Quarter of Fiscal Year 2021. Today's call is being recorded. Before we get started, I would like to remind everyone that during this conference call, AGTC may make forward-looking statements, including statements about the company's financial results, finance, its future business strategies and operations and its product development and regulatory progress, including statements about the projected timing for its planned Vista and SkyLine clinical trials. The timing for
For further details see:
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q2 2021 Results - Earnings Call Transcript